Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Lilly Abemaciclib Research Grant Opportunity: Submit by Friday, July 10, 2020
Study Proposal Submission-NCCN iEnvision
NCCN Pfizer Axitinib Research Grant Opportunity: Submit by Wednesday, August 12, 2020
NCCN Pfizer Biosimilars Grant Opportunity - Submit by Wednesday, September 9, 2020
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

Find a clinical trial >


The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins was one of the first cancer centers in the country designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center established under the National Cancer Act. It is the only NCI Comprehensive Cancer Center in the state of Maryland. This designation means the Center has active programs in clinical research, laboratory research, education, community outreach, and prevention and control. It has won further recognition as one of the first "Centers of Excellence."

Well known for its excellence in the diagnosis, treatment, and prevention of cancer, the Center is dedicated to better understanding human cancers and developing multidisciplinary therapeutic approaches for the treatment of solid tumors and hematological malignancies.

A leader on many fronts, the Sidney Kimmel Comprehensive Cancer Center is internationally recognized for its programs in the molecular genetics of cancer, bone marrow transplantation, new drug development, pediatric oncology, radiation oncology, brain tumor research and treatment, and esophageal cancer research, treatment and prevention. The Center is also highly regarded for its premiere research involving the genetic basis of colon cancer, the treatment of cancer pain, gene therapy, and new therapeutic approaches for breast cancer.

The Kimmel Cancer Center encompasses a wide spectrum of specialty programs in breast, colon, melanoma, hematologic malignancies, and head and neck cancers. Additionally, those at high-risk for breast, ovarian, colon, and other cancers may seek information about early detection, prevention, and genetic counseling through a comprehensive genetics service.

As pioneers in the genetic revolution, Hopkins is identifying and studying high-risk populations and was the first to develop blood tests to identify inherited genetic mutations which lead to a cancer predisposition. This leadership role earned the Kimmel Cancer Center a five-year, $3.8 million grant from the National Cancer Institute to establish the Mid-Atlantic Cancer Genetics Network, one of just eight institutions in the country charged with learning more about the genetic basis of cancer susceptibility and translating this new knowledge to patient care.

The Kimmel Cancer Center at Johns Hopkins also offers family and patient services including oncology social work, pastoral care, a Cancer Counseling Center, survivors and palliative care programs, outpatient pharmacy, home care, patient and family education, and a new 39-suite patient and family pavilion for out-of-town patients. The Kimmel Cancer Center's nurses are on the cutting edge of clinical care, conducting research and developing models for patient care. Our nursing teams are trained to provide top-notch service - whether it be round-the-clock care in our inpatient units, continual diagnosis and therapy at our outpatient clinics, or detailed monitoring during our clinical trials research.

Patients receive the utmost attention and quality care. With so many professional registered nurses practicing in different roles, serve broad range of oncology expertise, ensuring that care is tailored to patients' specific needs.

We also specialize in compassion and hope. We comfort. We monitor. We teach at the bedside. All this contributes to a highly professional nursing environment - a factacknowledged by the Cancer Center's elite designation as a Magnet hospital, the highest nursing honor in the worldthat a hospital can receive.

Hopkins has furthered its commitment to excellence in patient care and research by building three new facilities to enhance the Kimmel Cancer Center's ongoing programs and services and promote new developments in cancer research, treatment, and prevention.

The Harry and Jeannette Weinberg Building is 350,000 square foot facility for our clinical cancer services, including radiation oncology, radiology, operating rooms, surgical intensive care units, inpatient units for solid tumors and hematologic malignancies, a specialized inpatient-outpatient clinic for stem cell and bone marrow transplant patients, pharmacy, and outpatient chemotherapy.

The Bunting Blaustein Cancer Research Building is a ten-story laboratory research facility with programs in cancer biology, hematological malignancies, urological oncology, gastrointestinal cancer, solid tumor research, pharmacology, and experimental therapeutics, and cancer prevention and control. The David S. Koch Cancer Research mirrors the design of the Bunting ? Blaustein Building and connects to it. It houses research programs in prostate, brain, pancreas, skin, lung, and head and neck cancers.

The Sidney Kimmel Comprehensive Cancer Center has, over the last decade, reduced hospital stays and treatment-related complication resulting in a dramatic cut in costs for even the most intensive therapies. At the same time, they dramatically advance medical knowledge, contributing to future savings in terms of both human and monetary costs. The institution is committed to its mission of teaching, research, and patient care.